Abstract
Ovulation induction has been an important mode of treatment of infertility. Ovarian stimulation may result in a supraphysiologic response leading to an iatrogenic complication known as the ovarian hyperstimulation syndrome (OHSS). This syndrome is potentially a lethal condition, the pathophysiologic hallmark of which is the accumulation of massive extravascular exudate combined with profound intravascular volume depletion and hemoconcentration. We report a case of severe OHSS with very large ovaries in a 35 year old case of embryo transfer. The patient presented to the emergency department with abdominal pain, massive ascites, respiratory distress and amenorrhea. The patient was managed symptomatically with no complications. Although ovarian hyperstimulation is a rare entity, it is important that the physician recognizes this condition. Prompt diagnosis and successful management is likely to avoid serious and rapid development of complications.
References
Alper MM, Smith LP, Sills ES. Ovarian hyperstimulation syndrome: current views on pathophysiology, risk factors, prevention, and management. J Exp Clin Assist Reprod. 2009;6:3.
Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: pathophysiology and prevention. J Assist Reprod Genet. 2010;27:121–8.
Fiedler K, Ezcurra D. Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol. 2012;10:32.
D’Angelo A, Davies R, Salah E, Nix BA, Amso NN. Value of the serum estradiol level for preventing ovarian hyperstimulation syndrome: a retrospective case control study. Fertil Steril. 2004;81(2):332–6.
Grossman LC, Michalakis KG, Browne H, Payson MD, Segars JH. The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome. Fertil Steril. 2010;94(4):1392–8.
Gysler M, Hemmings R, Cheung AP, Goodrow GJ, Hughes EG, Min JK, et al. The diagnosis and management of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can. 2011;33(11):1156–62.
Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome: views and ideas. Hum Reprod. 1997;12(6):1129–37.
Nabriski D, Ellis M, Ness-Abramof R, Shapiro M, Shenkman L. Autoimmune thyroid disease and antiphospholipid antibodies. Am J Hematol. 2000;64(1):73–5.
Papanikolaou EG, Humaidan P, Polyzos N, Kalantaridou S, Kol S, Benadiva C, et al. New algorithm for OHSS prevention. Reprod Biol Endocrinol. 2011;9:147.
Choi MH, Lee SH, Kim HO, Cha SH, Kim JY, Yang KM, et al. Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: in vitro maturation, GnRH agonist, and GnRH antagonist cycles. Clin Exp Reprod Med. 2012;39(4):166–71.
Rabinerson D, Shalev J, Royburt M, Ben-Rafael Z, Dekel A. Severe unilateral hydrothorax as the only manifestation of the ovarian hyperstimulation syndrome. Gynecol Obstet Invest. 2000;49:140–2.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lodh, M., Mukhopadhyay, J. & Sharma, V. A Case of Severe Ovarian Hyperstimulation Syndrome. Ind J Clin Biochem 29, 386–389 (2014). https://doi.org/10.1007/s12291-013-0390-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-013-0390-4